0001415889-23-006472.txt : 20230412
0001415889-23-006472.hdr.sgml : 20230412
20230412163007
ACCESSION NUMBER: 0001415889-23-006472
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230410
FILED AS OF DATE: 20230412
DATE AS OF CHANGE: 20230412
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DWEK RAYMOND
CENTRAL INDEX KEY: 0001231617
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26301
FILM NUMBER: 23816018
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: UNITED THERAPEUTICS Corp
CENTRAL INDEX KEY: 0001082554
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 521984749
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1040 SPRING ST
CITY: SILVER SPRING
STATE: MD
ZIP: 20910
BUSINESS PHONE: 3016089292
MAIL ADDRESS:
STREET 1: 1040 SPRING ST
CITY: SILVER SPRING
STATE: MD
ZIP: 20910
FORMER COMPANY:
FORMER CONFORMED NAME: UNITED THERAPEUTICS CORP
DATE OF NAME CHANGE: 19990324
4
1
form4-04122023_040401.xml
X0407
4
2023-04-10
0001082554
UNITED THERAPEUTICS Corp
UTHR
0001231617
DWEK RAYMOND
C/O UNITED THERAPEUTICS CORPORATION
1040 SPRING STREET
SILVER SPRING
MD
20910
true
false
false
false
0
Common Stock
2023-04-10
4
M
0
3000
63.90
A
3000
D
Common Stock
2023-04-10
4
D
0
3000
223.07
D
0
D
Share Tracking Award
63.90
2023-04-10
4
M
0
3000
0
D
2014-06-26
2023-06-26
Common Stock
3000
4000
D
This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.
/s/ John S. Hess, Jr. under Power of Attorney
2023-04-12